906 related articles for article (PubMed ID: 18172324)
1. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
2. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
3. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.
Wentzensen N; Ridder R; Klaes R; Vinokurova S; Schaefer U; Doeberitz Mv
Oncogene; 2002 Jan; 21(3):419-26. PubMed ID: 11821954
[TBL] [Abstract][Full Text] [Related]
4. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
5. Papillomavirus genomes in human cervical carcinoma: analysis of their integration and transcriptional activity.
Matulić M; Sorić J
Neoplasma; 1994; 41(2):95-100. PubMed ID: 8208320
[TBL] [Abstract][Full Text] [Related]
6. Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis.
Ho CM; Lee BH; Chang SF; Chien TY; Huang SH; Yan CC; Cheng WF
Virus Res; 2011 Nov; 161(2):124-30. PubMed ID: 21777630
[TBL] [Abstract][Full Text] [Related]
7. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
8. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
Schmitt M; Dalstein V; Waterboer T; Clavel C; Gissmann L; Pawlita M
Cancer Res; 2010 Jan; 70(1):249-56. PubMed ID: 20028865
[TBL] [Abstract][Full Text] [Related]
10. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia.
Hillemanns P; Wang X
Gynecol Oncol; 2006 Feb; 100(2):276-82. PubMed ID: 16300821
[TBL] [Abstract][Full Text] [Related]
11. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
12. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
13. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
14. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
15. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
16. [Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions].
Li Y; Xiang Y; Zhang RF; Cai YP; Yang Y; Cheng XM; Zhu BL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):906-10. PubMed ID: 21600119
[TBL] [Abstract][Full Text] [Related]
17. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
18. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
19. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
[TBL] [Abstract][Full Text] [Related]
20. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
Alazawi W; Pett M; Arch B; Scott L; Freeman T; Stanley MA; Coleman N
Cancer Res; 2002 Dec; 62(23):6959-65. PubMed ID: 12460913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]